Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy

NCT07150299 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07150299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07150299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2025
Completion date
September 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic obstructive cardiomyopathy \(hocm\)